Department of General, Visceral, Transplantation, Vascular and Pediatric Surgery, Center of Operative Medicine (ZOM), University Hospital of Wuerzburg, Wuerzburg, Germany.
Department of Medical Education and Education Research, University of Wuerzburg, Wuerzburg, Germany.
Langenbecks Arch Surg. 2024 Oct 8;409(1):299. doi: 10.1007/s00423-024-03485-8.
Evidence from Asian studies suggests that minimally-invasive gastrectomy achieves equivalent oncological but improved perioperative outcomes compared to open surgery. Oncological gastric resections are less frequent in European countries. Index procedures may play a role for the learning curve of minimally-invasive gastrectomy. The aim of our study was to evaluate if skills acquired in bariatric surgery allow a safe and oncologically adequate implementation of minimally-invasive gastrectomy in a cohort of european patients.
In this single-center retrospective study, all patients who received primary bariatric surgery between January 2015 and December 2018 and minimally-invasive surgery for gastric cancer treated from June 2019 to January 2023 were evaluated. Primary endpoints were operation time, lymph node yield and lymph node fractions. Secondary endpoints included postoperative complications and oncological outcomes.
Learning curves for two surgeons with 350 bariatric procedures and 44 minimally-invasive gastrectomies were analyzed. For bariatric surgery, the mean operation time decreased from initially 82 ± 27 to 45 ± 21 min and 118 ± 28 to 81 ± 36 min for sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB), while the complication rate remained within the international benchmark. For laparoscopic gastrectomy (n = 30), operation times decreased but then remained stable over time. Operation times for the robotic platform were longer (302 ± 60 vs. 390 ± 48 min; p < 0.001) with the learning curve remaining incomplete after 14 procedures. R0 status was achieved in 95.5% of patients; the mean number of lymph nodes retrieved was 37 ± 14 with no differences between the groups. Complete mesogastric excision was more frequently achieved during the later laparoscopic cases whereas it occurred earlier for the robotic group (p = 0.004). Perioperative morbidity was comparable to the European benchmark. Textbook outcome was achieved in 54.4% of the cases.
In summary, we could demonstrate a successful skill transfer from bariatric surgery to minimally-invasive laparoscopic oncological gastric surgery enabling safe and oncologically adequate minimally-invasive D2 gastrectomy in a central European patient collective.
亚洲的研究证据表明,与开放性手术相比,微创胃切除术在肿瘤学方面具有等效效果,但围手术期结果更佳。在欧洲国家,胃的肿瘤切除术较少。索引手术可能在微创胃切除术的学习曲线上发挥作用。我们的研究目的是评估在欧洲患者队列中,从减重手术中获得的技能是否可以安全且在肿瘤学上合理地实施微创胃切除术。
在这项单中心回顾性研究中,评估了 2019 年 6 月至 2023 年 1 月期间接受过原发性减重手术(2015 年 1 月至 2018 年 12 月)和微创胃癌手术的所有患者。主要终点为手术时间、淋巴结产量和淋巴结分数。次要终点包括术后并发症和肿瘤学结果。
分析了两名外科医生进行的 350 例减重手术和 44 例微创胃切除术的学习曲线。对于减重手术,袖状胃切除术(SG)和 Roux-en-Y 胃旁路术(RYGB)的平均手术时间分别从最初的 82±27 分钟减少到 45±21 分钟和 118±28 分钟,而并发症发生率仍保持在国际基准范围内。对于腹腔镜胃切除术(n=30),手术时间减少,但随后保持稳定。机器人平台的手术时间较长(302±60 分钟与 390±48 分钟;p<0.001),在进行 14 例手术后,学习曲线仍未完成。95.5%的患者达到了 R0 状态;切除的淋巴结平均数量为 37±14,两组之间无差异。完整的中胃系膜切除在后来的腹腔镜病例中更常见,而机器人组则更早发生(p=0.004)。围手术期发病率与欧洲基准相当。在 54.4%的病例中达到了教科书结果。
总之,我们能够证明从减重手术到微创腹腔镜肿瘤胃手术的成功技能转移,使在中欧患者群体中安全且在肿瘤学上合理地实施微创 D2 胃切除术成为可能。